| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Contrat Jeune Formation, Institut National de la Santé et de la Recherche Médicale 9503, Centre Claudius Régaud, Toulouse Cedex 31052 [V. M., G. L., A. B., J-P. J.]; Laboratoire de Biochimie Médicale, Institut National de la Santé et de la Recherche Médicale U466, Centre Hospitalier Universitaire Rangueil, Toulouse 31403 [T. L.]; and Service d'Hématologie Centre Hospitalier Universitaire Purpan, Toulouse 31059 [G. L.], France
To address the role of protein kinase C (PKC) in the regulation of ceramide production, we evaluated the impact of the PKC activators 12-O-tetradecanoylphorbol-13-acetate and phosphatidylserine on the apoptotic signaling pathway triggered by the chemotherapeutic drug daunorubicin. Treatment of U937 and HL-60 cells with 0.51 µM daunorubicin induced a greater than 30% activation of neutral sphingomyelinase activity within 410 min with concomitant sphingomyelin hydrolysis and ceramide generation. Activation of PKC by 12-O-tetradecanoylphorbol-13-acetate and phosphatidylserine inhibited daunorubicin-induced neutral sphingomyelinase activation, sphingomyelin hydrolysis, ceramide generation, and apoptosis. The apoptotic response could be restored by the addition of 25 µM cell-permeant C6-ceramide. In conclusion, PKC emerges as a potentially critical negative regulator of the anthracycline-activated sphingomyelin-ceramide apoptotic pathway.
1 This study was supported in part by Grant 96003115 from La Fédération Nationale des Centres de Lutte Contre le Cancer (to J-P. J. and T. L.); by a grant from the Conseil Régional Midi-Pyrées (to T. L. and J-P. J.); by l'Association pour la Recherche sur le Cancer Grants 6749 (to G. L.), 3002 (to T. L.), and 2069 (to J-P. J.); and by a grant from La Ligue Nationale Contre le Cancer (to G. L.). V. M. is the recipient of an Institut National de la Santé et de la Recherche Médicale fellowship.
2 To whom requests for reprints should be addressed, at CJF INSERM 9503, Centre Claudius Régaud, 20 rue du Pont St. Pierre, Toulouse Cedex 31052 France. E-mail: jaffrezou@regaud-tlse.fnclcc.fr.
Received 5/ 1/97. Accepted 10/ 3/97.
This article has been cited by other articles:
![]() |
O. Humbert, I. Achour, D. Lautier, G. Laurent, and B. Salles hMSH2 expression is driven by AP1-dependent regulation through phorbol-ester exposure Nucleic Acids Res., October 1, 2003; 31(19): 5627 - 5634. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Minamino, I. Sakaguchi, T. Naka, N. Ikeda, Y. Kato, I. Tomiyasu, I. Yano, and K. Kobayashi Bacterial ceramides and sphingophospholipids induce apoptosis of human leukaemic cells Microbiology, August 1, 2003; 149(8): 2071 - 2081. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bezombes, A. de Thonel, A. Apostolou, T. Louat, J.-P. Jaffrezou, G. Laurent, and A. Quillet-Mary Overexpression of Protein Kinase Czeta Confers Protection Against Antileukemic Drugs by Inhibiting the Redox-Dependent Sphingomyelinase Activation Mol. Pharmacol., December 1, 2002; 62(6): 1446 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maddens, A. Charruyer, I. Plo, P. Dubreuil, S. Berger, B. Salles, G. Laurent, and J.-P. Jaffrezou Kit signaling inhibits the sphingomyelin-ceramide pathway through PLCgamma 1: implication in stem cell factor radioprotective effect Blood, July 30, 2002; 100(4): 1294 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Humbert, T. Hermine, H. Hernandez, T. Bouget, J. Selves, G. Laurent, B. Salles, and D. Lautier Implication of Protein Kinase C in the Regulation of DNA Mismatch Repair Protein Expression and Function J. Biol. Chem., May 10, 2002; 277(20): 18061 - 18068. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Laurent and J.-P. Jaffrezou Signaling pathways activated by daunorubicin Blood, August 15, 2001; 98(4): 913 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fettucciari, E. Rosati, L. Scaringi, P. Cornacchione, G. Migliorati, R. Sabatini, I. Fetriconi, R. Rossi, and P. Marconi Group B Streptococcus Induces Apoptosis in Macrophages J. Immunol., October 1, 2000; 165(7): 3923 - 3933. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Allouche, R. S. Charrad, A. Bettaieb, C. Greenland, C. Grignon, and F. Smadja-Joffe Ligation of the CD44 adhesion molecule inhibits drug-induced apoptosis in human myeloid leukemia cells Blood, August 1, 2000; 96(3): 1187 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ferraro, L. Quemeneur, A.-F. Prigent, C. Taverne, J.-P. Revillard, and N. Bonnefoy-Berard Anthracyclines Trigger Apoptosis of Both G0-G1 and Cycling Peripheral Blood Lymphocytes and Induce Massive Deletion of Mature T and B Cells Cancer Res., April 1, 2000; 60(7): 1901 - 1907. [Abstract] [Full Text] |
||||
![]() |
T. Kondo, T. Matsuda, M. Tashima, H. Umehara, N. Domae, K. Yokoyama, T. Uchiyama, and T. Okazaki Suppression of Heat Shock Protein-70 by Ceramide in Heat Shock-induced HL-60 Cell Apoptosis J. Biol. Chem., March 17, 2000; 275(12): 8872 - 8879. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M.-D. Mas, C. Bezombes, A. Quillet-Mary, A. Bettaïeb, A. D. T. D'orgeix, G. Laurent, and J.-P. Jaffrézou Implication of Radical Oxygen Species in Ceramide Generation, c-Jun N-Terminal Kinase Activation and Apoptosis Induced by Daunorubicin Mol. Pharmacol., November 1, 1999; 56(5): 867 - 874. [Abstract] [Full Text] |
||||
![]() |
A. Laouar, D. Glesne, and E. Huberman Involvement of Protein Kinase C-beta and Ceramide in Tumor Necrosis Factor-alpha -induced but Not Fas-induced Apoptosis of Human Myeloid Leukemia Cells J. Biol. Chem., August 13, 1999; 274(33): 23526 - 23534. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bettaïeb, I. Plo, V. Mansat-De Mas, A. Quillet-Mary, T. Levade, G. Laurent, and J.-P. Jaffrézou Daunorubicin- and Mitoxantrone-Triggered Phosphatidylcholine Hydrolysis: Implication in Drug-Induced Ceramide Generation and Apoptosis Mol. Pharmacol., January 1, 1999; 55(1): 118 - 125. [Abstract] [Full Text] |
||||
![]() |
B. A. Wagner, G. R. Buettner, L. W. Oberley, C. J. Darby, and C. P. Burns Myeloperoxidase Is Involved in H2O2-induced Apoptosis of HL-60 Human Leukemia Cells J. Biol. Chem., July 14, 2000; 275(29): 22461 - 22469. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Paris, H. Grassme, A. Cremesti, J. Zager, Y. Fong, A. Haimovitz-Friedman, Z. Fuks, E. Gulbins, and R. Kolesnick Natural Ceramide Reverses Fas Resistance of Acid Sphingomyelinase-/- Hepatocytes J. Biol. Chem., March 9, 2001; 276(11): 8297 - 8305. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |